Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Ultrasmall platinum nanoparticles for radiation-enhanced cancer therapy

  • Encinas-Giménez, Miguel
  • García-Peiro, José I.
  • Hueso, José L.
  • Caleiras, Eduardo
  • Notario, Laura
  • Hornos, Felipe
  • Martín-Duque, Pilar
  • Vieja, Antonio de la
  • Santamaría, Jesús
Despite decades of intense research, cancer remains a major global health challenge, with a clear need for new and more efficient therapies. Among emerging approaches, high atomic number (Z) nanomaterials capable of modulating the interaction between radiation and matter have attracted growing interest as radiotherapy enhancers. In this work, ultra-small Platinum-based nanoparticles with a metallic core diameter of 2–3 nm were synthesized from H2PtCl6 using polyvinylpyrrolidone as stabilizer. This nanomaterial exhibits low acute toxicity, catalase-like activity and enhances DNA damage under pre-clinical X-ray irradiation, increasing the antitumoral effect of X-ray alone. In vitro and in vivo studies, including intratumoral and intravenous administration, demonstrate improved tumor control and prolonged survival without detectable systemic toxicity under the tested conditions, establishing ultra-small Pt-nanoparticles as efficient materials for radiotherapy enhancement., The authors would like to acknowledge funding from the ERC Advanced Grant CADENCE project number 742684 and from Spanish Government Grant PID2023-148732NB-100. A.D.L.V acknowledges the Spanish Government grant PID2021-125948OB-I00 from MCIN/AEI/10.13039/501100011033/FEDER (UE) and P.M.D funding from Instituto de Salud Carlos lll, AESI 2024 PI24CIII/00046 and Ministerio de Ciencia, Innovación y Universidades. CNS2023-145442. The authors also thank CIBER-BBN, an initiative funded by the VI National R&D&i Plan 2008–2011 financed by the Instituto de Salud Carlos III (ISCIII) with the assistance of the European Regional Development Fund. M.E.G. and J.I.G.P. acknowledge the Aragon Regional Government for their predoctoral contracts. F.H. acknowledges the Generalitat Valenciana and the European Social Fund for an APOSTD fellowship (APOSTD/2021/196). The study was also supported by the Aragon Government via Research Group T57_23R. Severo Ochoa (CEX2023-001286-S) is acknowledged by MICIU/AEI/10.13039/501100011033., With funding from the Spanish government through the "Severo Ochoa Centre of Excellence" accreditation (CEX2023-001286-S)., Peer reviewed
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Detection of Adenoviral E1A Gene in Guthrie Cards for Insights into Pediatric Cancer Origin

  • Mendoza, Gracia
  • Guerrero, Rebeca
  • Strunk, Mark
  • Calvo, Carlota
  • González-Irazabal, Yolanda
  • Álvarez, Ramiro
  • Gómez-Sirvent, Jorge E.
  • López-Almaraz, Ricardo
  • Hernández-Losa, Javier
  • Ramón y Cajal, Santiago
  • González-Pastor, Rebeca
  • Martin-Duque, Pilar
Adenoviruses have been implicated in childhood cancers, primarily leukemia, yet prior neonatal investigations have rarely examined other pediatric tumor types. This study evaluated whether adenoviral early region (E1A) sequences can be detected in archival neonatal Guthrie cards from children who later developed diverse pediatric tumors and in corresponding paraffin-embedded tissues. DNA extraction was optimized for long-stored dried blood spots, and PCR conditions were refined for both Guthrie card and paraffin-derived DNA. Adenoviral E1A was analyzed using conventional and nested PCR, and sequencing of representative amplicons confirmed correspondence to human adenovirus species C. E1A PCR positivity was found in 43% of Guthrie cards from cases (n = 54) and 34% of controls (n = 32), and in 41% of tumor tissues (n = 75) compared with 5% of non-tumor paraffin controls (n = 20). Detection occurred across multiple tumor categories without a clear association with tumor type. Partial concordance was observed between paired neonatal and tumor samples, and cytomegalovirus markers were detected in a subset of E1A-positive specimens. These findings confirm the suitability of Guthrie cards for retrospective viral DNA detection and extend previous leukemia-focused neonatal studies to broader pediatric tumors. The data suggest a potential association between birth-stage adenoviral detection and childhood cancer, though a causal link remains unproven and requires further longitudinal investigation.